Melanoma Trial, Recruiting (NCT06899789)

Melanoma Trial, Recruiting NCT06899789 Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT06899789 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
You must be able to give your consent to participate, or in some cases your existing data may be used for the research portion of the study (rules may vary by country)
You must have received at least one round of a type of cancer treatment called immune checkpoint inhibitors before developing bowel or gut symptoms
You must have had at least one colonoscopy that showed signs of bowel inflammation (colitis) after starting immune checkpoint inhibitor treatment; if your data is being used from the past, there must be at least 12 months of follow-up records available, unless you passed away before that time

Who may not be able to join:

You may not be eligible if you had colitis or inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) before you started immune checkpoint inhibitor treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390382502183

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06899789

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: +390382502183

More information: https://clinicaltrials.gov/study/NCT06899789

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
You must be able to give your consent to participate, or in some cases your existing data may be used for the research portion of the study (rules may vary by country)
You must have received at least one round of a type of cancer treatment called immune checkpoint inhibitors before developing bowel or gut symptoms
You must have had at least one colonoscopy that showed signs of bowel inflammation (colitis) after starting immune checkpoint inhibitor treatment; if your data is being used from the past, there must be at least 12 months of follow-up records available, unless you passed away before that time

Who may not be able to join:

You may not be eligible if you had colitis or inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) before you started immune checkpoint inhibitor treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Registry

ClinicalTrials.gov

Start date

29 July 2022

Est. completion

31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

The primary endpoint is the rate of clinical remission defined as symptoms CTCAE grade 1 or less within 12 months after CIC diagnosis (at the last evaluation available when death occurs or at one year from diagnosis).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov